{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:34:33Z","timestamp":1776238473090,"version":"3.50.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2008,3,5]],"date-time":"2008-03-05T00:00:00Z","timestamp":1204675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001741","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T22:58:10Z","timestamp":1204671490000},"page":"e1741","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation"],"prefix":"10.1371","volume":"3","author":[{"given":"Vikram","family":"Paruchuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari K.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornelia","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh K.","family":"Ganju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2008,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12484041","article-title":"Molecular cloning, occurrence, and expression of a novel partially secreted protein \u201cpsoriasin\u201d that is highly up-regulated in psoriatic skin.","volume":"97","author":"P Madsen","year":"1991","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00432-006-0164-y","article-title":"Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.","volume":"133","author":"N Moubayed","year":"2007","journal-title":"J Cancer Res Clin Oncol;"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-3-1","article-title":"Psoriasin (S100A7) expression is altered during skin tumorigenesis.","volume":"3","author":"S Alowami","year":"2003","journal-title":"BMC Dermatol;"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-5-17","article-title":"Expression analysis of the mouse S100A7\/psoriasin gene in skin inflammation and mammary tumorigenesis.","volume":"5","author":"M Webb","year":"2005","journal-title":"BMC Cancer;"},{"key":"ref5","first-page":"4111","article-title":"Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.","volume":"57","author":"M Ostergaard","year":"1997","journal-title":"Cancer Res;"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)65524-1","article-title":"Psoriasin (S100A7) expression and invasive breast cancer.","volume":"155","author":"S Al-Haddad","year":"1999","journal-title":"Am J Pathol;"},{"key":"ref7","first-page":"362","article-title":"Molecular markers in ductal carcinoma in situ of the breast.","volume":"1","author":"D Porter","year":"2003","journal-title":"Mol Cancer Res;"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1158\/0008-5472.CAN-04-3927","article-title":"The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.","volume":"65","author":"ED Emberley","year":"2005","journal-title":"Cancer Res;"},{"key":"ref9","first-page":"1027","article-title":"The HER2 (c-erbB-2) oncogene is frequently amplified in situ carcinomas of the breast.","volume":"7","author":"E Liu","year":"1992","journal-title":"Oncogene;"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00665957","article-title":"EGF receptor in neoplasia and metastasis.","volume":"12","author":"K Khazaie","year":"1993","journal-title":"Cancer Metastasis Rev;"},{"key":"ref11","first-page":"19","article-title":"Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.","volume":"1","author":"R Radinsky","year":"1995","journal-title":"Clin Cancer Res;"},{"key":"ref12","first-page":"268; author reply 269","article-title":"Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation","volume":"14","author":"AR Silva","year":"2006","journal-title":"Int J Surg Pathol;"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signaling.","volume":"284","author":"RN Jorissen","year":"2003","journal-title":"Exp Cell Res;"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"11326","DOI":"10.1158\/0008-5472.CAN-05-1523","article-title":"A putative role for psoriasin in breast tumor progression.","volume":"65","author":"I Krop","year":"2005","journal-title":"Cancer Res;"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1646::AID-CNCR14>3.0.CO;2-#","article-title":"Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma.","volume":"80","author":"HA Harvey","year":"1997","journal-title":"Cancer;"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00666208","article-title":"Osteolytic bone metastasis in breast cancer.","volume":"32","author":"T Yoneda","year":"1994","journal-title":"Breast Cancer Res Treat;"},{"key":"ref17","article-title":"Breast cancer metastasis to bone: it is not all about PTHrP.","volume":"S39-45","author":"M Bendre","year":"2003","journal-title":"Clin Orthop Relat Res;"},{"key":"ref18","first-page":"5571","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.","volume":"62","author":"MS Bendre","year":"2002","journal-title":"Cancer Res;"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1096\/fasebj.13.14.1939","article-title":"c-erbB-2\/EGFR as dominant heterodimerization partners determine a mitogenic phenotype in human breast cancer cells.","volume":"13","author":"BH Brandt","year":"1999","journal-title":"Faseb J;"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1","article-title":"The EGF receptor: a nexus for trafficking and signaling.","volume":"22","author":"G Carpenter","year":"2000","journal-title":"Bioessays;"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/j.1460-2075.1996.tb00356.x","article-title":"ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.","volume":"15","author":"D Karunagaran","year":"1996","journal-title":"Embo J;"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1200\/JCO.2005.09.055","article-title":"Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.","volume":"23","author":"MP Di Giovanna","year":"2005","journal-title":"J Clin Oncol;"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1158\/0008-5472.CAN-06-2580","article-title":"Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior.","volume":"67","author":"M Dimri","year":"2007","journal-title":"Cancer Res;"},{"key":"ref24","first-page":"2940","article-title":"Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.","volume":"63","author":"KL Weber","year":"2003","journal-title":"Cancer Res;"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/erc.1.01100","article-title":"Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.","volume":"13","author":"A Angelucci","year":"2006","journal-title":"Endocr Relat Cancer;"},{"key":"ref26","first-page":"2627","article-title":"Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.","volume":"9","author":"ED Emberley","year":"2003","journal-title":"Clin Cancer Res;"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1465-9921-6-118","article-title":"Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry.","volume":"6","author":"M Bryborn","year":"2005","journal-title":"Respir Res;"},{"key":"ref28","first-page":"1954","article-title":"Psoriasin interacts with Jab1 and influences breast cancer progression.","volume":"63","author":"ED Emberley","year":"2003","journal-title":"Cancer Res;"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/S0021-9258(18)68968-9","article-title":"Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation.","volume":"263","author":"PJ Bertics","year":"1988","journal-title":"J Biol Chem;"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1021\/bi00050a029","article-title":"In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.","volume":"34","author":"CR Lombardo","year":"1995","journal-title":"Biochemistry;"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/ijc.21492","article-title":"Her-2\/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer.","volume":"118","author":"G Hudelist","year":"2006","journal-title":"Int J Cancer;"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc1837","article-title":"Protein-tyrosine phosphatases and cancer.","volume":"6","author":"A Ostman","year":"2006","journal-title":"Nat Rev Cancer;"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","article-title":"Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling.","volume":"8","author":"W Lu","year":"2001","journal-title":"Mol Cell;"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/sj.bjc.6603444","article-title":"Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity.","volume":"95","author":"GR Wilson","year":"2006","journal-title":"Br J Cancer;"},{"key":"ref35","first-page":"4773","article-title":"Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.","volume":"52","author":"AE Ottenhoff-Kalff","year":"1992","journal-title":"Cancer Res;"},{"key":"ref36","first-page":"516","article-title":"Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue.","volume":"49","author":"A Hennipman","year":"1989","journal-title":"Cancer Res;"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-4804(02)00100-2","article-title":"Epidermal growth factor stimulation can substitute for c-Src overexpression in promoting breast carcinoma invasion.","volume":"109","author":"M Lotz","year":"2003","journal-title":"J Surg Res;"},{"key":"ref38","first-page":"5849","article-title":"Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.","volume":"59","author":"L Pederson","year":"1999","journal-title":"Cancer Res;"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","article-title":"Molecular mechanisms of breast cancer metastases to bone.","volume":"5","author":"TA Guise","year":"2005","journal-title":"Clin Breast Cancer;"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma.","volume":"97","author":"SM Kakonen","year":"2003","journal-title":"Cancer;"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2001.19.15.3562","article-title":"Biology of osteoclast activation in cancer.","volume":"19","author":"GD Roodman","year":"2001","journal-title":"J Clin Oncol;"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr1648","article-title":"Oestrogen receptor negative breast cancers exhibit high cytokine content.","volume":"9","author":"C Chavey","year":"2007","journal-title":"Breast Cancer Res;"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jss.2006.03.018","article-title":"Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.","volume":"134","author":"B Singh","year":"2006","journal-title":"J Surg Res;"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.ejca.2004.05.024","article-title":"Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy.","volume":"40","author":"D Chelouche-Lev","year":"2004","journal-title":"Eur J Cancer;"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.pai.0000168591.58721.a6","article-title":"HER2 is unlikely to be involved in directly regulating angiogenesis in human breast cancer.","volume":"14","author":"G Vogl","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol;"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-04-4559","article-title":"ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of Rapamycin\/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.","volume":"66","author":"KS Klos","year":"2006","journal-title":"Cancer Res;"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T06:33:49Z","timestamp":1630823629000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001741"}},"subtitle":[],"editor":[{"given":"Mikhail V.","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,3,5]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001741","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,5]]}}}